Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Shmuel Yaccoby

Concepts (332)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
63
2023
2990
4.810
 Why?
Osteoclasts
17
2015
427
2.490
 Why?
Bone Diseases
7
2014
96
2.240
 Why?
Osteoblasts
13
2012
463
1.440
 Why?
Gene Expression Regulation, Neoplastic
12
2018
831
1.270
 Why?
Osteolysis
6
2013
74
1.220
 Why?
Boronic Acids
12
2013
182
1.180
 Why?
Neoplasm Proteins
6
2018
320
1.170
 Why?
Coculture Techniques
12
2015
140
1.160
 Why?
Mice, SCID
17
2015
171
0.980
 Why?
Bone Marrow Cells
5
2015
195
0.980
 Why?
Cell Differentiation
14
2018
640
0.940
 Why?
Bone and Bones
9
2014
481
0.920
 Why?
Pyrazines
11
2013
187
0.880
 Why?
Bone Marrow
8
2018
360
0.830
 Why?
Cell Proliferation
11
2023
980
0.790
 Why?
Mice
26
2015
5658
0.770
 Why?
Cell Communication
3
2015
70
0.740
 Why?
Intercellular Signaling Peptides and Proteins
4
2010
102
0.690
 Why?
Osteogenesis
5
2012
354
0.680
 Why?
Bone Resorption
4
2011
301
0.660
 Why?
Adipocytes
2
2018
126
0.630
 Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.610
 Why?
Animals
29
2016
13062
0.610
 Why?
Proteoglycans
4
2008
81
0.590
 Why?
Bone Neoplasms
2
2011
178
0.580
 Why?
Gene Expression
3
2018
605
0.570
 Why?
Humans
62
2023
50417
0.550
 Why?
Antineoplastic Agents
9
2015
1165
0.540
 Why?
Cell Movement
4
2013
244
0.530
 Why?
Neoplastic Stem Cells
1
2017
97
0.530
 Why?
Cell Survival
9
2015
587
0.520
 Why?
Protease Inhibitors
4
2010
58
0.510
 Why?
Tumor Microenvironment
2
2015
221
0.510
 Why?
Cytokines
3
2015
602
0.480
 Why?
Cysteine-Rich Protein 61
1
2014
3
0.460
 Why?
Plasma Cells
6
2009
220
0.440
 Why?
Nicotinamide Phosphoribosyltransferase
1
2013
6
0.410
 Why?
Angiogenesis Inhibitors
3
2010
183
0.410
 Why?
Membrane Glycoproteins
5
2009
246
0.400
 Why?
Protein-Tyrosine Kinases
1
2013
85
0.400
 Why?
Thalidomide
6
2016
375
0.390
 Why?
Mesenchymal Stem Cell Transplantation
1
2012
19
0.390
 Why?
Parathyroid Hormone
4
2010
149
0.370
 Why?
Gene Expression Profiling
7
2023
1020
0.370
 Why?
Up-Regulation
3
2013
446
0.370
 Why?
Wnt Proteins
2
2010
97
0.370
 Why?
Signal Transduction
6
2013
1608
0.340
 Why?
Rabbits
5
2013
369
0.330
 Why?
Receptor, EphB4
1
2009
5
0.320
 Why?
Ephrin-B2
1
2009
5
0.320
 Why?
Placenta
1
2011
134
0.320
 Why?
Disease Models, Animal
7
2016
1431
0.320
 Why?
Models, Biological
4
2010
717
0.320
 Why?
Fenretinide
1
2009
5
0.320
 Why?
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
1
2009
7
0.320
 Why?
Cell Line, Tumor
9
2015
1392
0.320
 Why?
Dipeptides
1
2009
22
0.310
 Why?
Antineoplastic Combined Chemotherapy Protocols
8
2016
997
0.310
 Why?
Cell Adhesion Molecules
1
2009
86
0.310
 Why?
Bone Development
1
2009
66
0.300
 Why?
Tumor Necrosis Factor Ligand Superfamily Member 13
1
2007
3
0.290
 Why?
Transmembrane Activator and CAML Interactor Protein
1
2007
6
0.290
 Why?
Apoptosis
8
2012
1092
0.290
 Why?
Extracellular Matrix Proteins
1
2008
66
0.290
 Why?
Disease Progression
6
2014
825
0.280
 Why?
Bone Remodeling
4
2012
148
0.270
 Why?
Recombinant Fusion Proteins
1
2007
186
0.270
 Why?
Neoplasm Recurrence, Local
3
2023
622
0.260
 Why?
Immunohistochemistry
5
2015
955
0.260
 Why?
Antibodies
1
2006
151
0.260
 Why?
Tumor Cells, Cultured
7
2013
453
0.250
 Why?
Serine Endopeptidases
1
2006
50
0.250
 Why?
RNA, Small Interfering
4
2013
208
0.250
 Why?
Transplantation, Heterologous
5
2009
73
0.250
 Why?
Antigens, Neoplasm
1
2006
148
0.240
 Why?
Prognosis
10
2018
1974
0.240
 Why?
Melphalan
2
2016
177
0.240
 Why?
Severe Combined Immunodeficiency
1
2005
11
0.230
 Why?
Neovascularization, Pathologic
4
2009
155
0.230
 Why?
Alkaline Phosphatase
6
2017
94
0.230
 Why?
NF-kappa B
4
2013
306
0.230
 Why?
Hematopoietic Stem Cells
3
2012
197
0.220
 Why?
Cell Division
5
2004
292
0.210
 Why?
Bone Density
3
2010
386
0.210
 Why?
Positron-Emission Tomography
2
2017
290
0.210
 Why?
Translocation, Genetic
2
2021
236
0.200
 Why?
Killer Cells, Natural
2
2015
107
0.200
 Why?
Stromal Cells
1
2003
75
0.200
 Why?
Transcription Factors
2
2023
561
0.200
 Why?
Immunophenotyping
2
2015
106
0.190
 Why?
Immunotherapy, Adoptive
2
2015
161
0.190
 Why?
Cell Line
2
2015
997
0.190
 Why?
T-Lymphocytes
2
2015
325
0.190
 Why?
Epigenomics
1
2021
65
0.180
 Why?
Bone Transplantation
4
2010
43
0.170
 Why?
Decorin
2
2012
7
0.170
 Why?
Antibodies, Monoclonal
3
2016
459
0.170
 Why?
Cells, Cultured
4
2013
1564
0.160
 Why?
Female
17
2018
27053
0.160
 Why?
Drug Resistance, Neoplasm
2
2015
315
0.160
 Why?
Syndecan-1
4
2007
73
0.160
 Why?
Genes, myc
1
2019
33
0.160
 Why?
Mice, Transgenic
4
2007
538
0.150
 Why?
Risk Factors
5
2018
3712
0.150
 Why?
Oligonucleotide Array Sequence Analysis
3
2009
400
0.140
 Why?
Cyclin-Dependent Kinases
2
2015
26
0.140
 Why?
Monoclonal Gammopathy of Undetermined Significance
2
2018
112
0.140
 Why?
Diffusion Magnetic Resonance Imaging
1
2018
124
0.140
 Why?
Hexokinase
1
2017
17
0.140
 Why?
Chromosome Aberrations
3
2016
279
0.140
 Why?
Chromosomes, Human, Pair 17
1
2017
34
0.140
 Why?
Tumor Suppressor Protein p53
2
2017
212
0.140
 Why?
Calcification, Physiologic
1
2017
40
0.130
 Why?
Proteasome Inhibitors
2
2016
104
0.130
 Why?
Pelvis
1
2017
66
0.130
 Why?
Stem Cells
2
2009
165
0.130
 Why?
Chromosome Deletion
1
2017
134
0.130
 Why?
Biopsy
2
2018
588
0.130
 Why?
Neoplasm, Residual
1
2017
161
0.130
 Why?
Neoplasms, Experimental
2
2007
111
0.130
 Why?
Base Sequence
2
2008
622
0.130
 Why?
Male
14
2018
25867
0.130
 Why?
Pyridinium Compounds
1
2015
21
0.130
 Why?
Gene Expression Regulation, Enzymologic
1
2017
178
0.130
 Why?
Fluorodeoxyglucose F18
1
2017
187
0.120
 Why?
Endothelial Cells
2
2009
256
0.120
 Why?
Homologous Recombination
1
2015
41
0.120
 Why?
Benzimidazoles
1
2015
49
0.120
 Why?
Xenograft Model Antitumor Assays
3
2015
210
0.120
 Why?
Peptide Nucleic Acids
1
2015
18
0.120
 Why?
Rad51 Recombinase
1
2015
23
0.120
 Why?
Genes, Neoplasm
1
2015
27
0.120
 Why?
Bromodeoxyuridine
2
2005
18
0.120
 Why?
Immunologic Factors
1
2016
113
0.120
 Why?
Flow Cytometry
5
2012
472
0.120
 Why?
Genomic Instability
1
2015
90
0.120
 Why?
Diphosphonates
2
2008
90
0.110
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2006
568
0.110
 Why?
Antigens, CD
1
2015
221
0.110
 Why?
Asymptomatic Diseases
1
2014
38
0.110
 Why?
Immunotherapy
1
2016
231
0.110
 Why?
Proteome
1
2015
161
0.110
 Why?
Time Factors
6
2017
2933
0.110
 Why?
Interleukin-6
2
2005
261
0.110
 Why?
Nicotinamide Mononucleotide
1
2013
4
0.100
 Why?
Acrylamides
1
2013
7
0.100
 Why?
Receptors, CXCR4
1
2013
28
0.100
 Why?
Poly(ADP-ribose) Polymerases
1
2013
29
0.100
 Why?
Niacinamide
1
2013
23
0.100
 Why?
Amides
1
2013
34
0.100
 Why?
NAD
1
2013
41
0.100
 Why?
Enzyme Induction
1
2013
78
0.100
 Why?
Nitriles
1
2013
52
0.100
 Why?
Sirtuin 1
1
2013
28
0.100
 Why?
Enzyme Inhibitors
2
2013
369
0.100
 Why?
Proteomics
1
2015
313
0.100
 Why?
beta Catenin
1
2013
96
0.100
 Why?
Chemokine CXCL12
1
2013
33
0.100
 Why?
Recurrence
2
2012
657
0.100
 Why?
Tumor Burden
2
2010
130
0.100
 Why?
Gene Knockdown Techniques
1
2013
104
0.100
 Why?
Oligopeptides
1
2013
94
0.100
 Why?
Magnetic Resonance Imaging
2
2012
1546
0.100
 Why?
Leukemia
1
2013
65
0.100
 Why?
Myelodysplastic Syndromes
1
2013
78
0.100
 Why?
Injections, Intravenous
1
2012
137
0.100
 Why?
Proto-Oncogene Proteins c-jun
2
2009
77
0.100
 Why?
Piperidines
1
2013
97
0.100
 Why?
Cytotoxicity, Immunologic
1
2012
57
0.100
 Why?
Remission Induction
1
2012
208
0.100
 Why?
Syndecans
3
2006
35
0.090
 Why?
Anti-Inflammatory Agents
1
2012
165
0.090
 Why?
Aged
8
2017
9738
0.090
 Why?
Lymph Nodes
1
2012
256
0.090
 Why?
beta 2-Microglobulin
2
2007
37
0.080
 Why?
JNK Mitogen-Activated Protein Kinases
2
2007
71
0.080
 Why?
Disease-Free Survival
3
2018
439
0.080
 Why?
Middle Aged
9
2018
12579
0.080
 Why?
Myocardium
1
2012
443
0.080
 Why?
Early Growth Response Protein 1
1
2009
34
0.080
 Why?
Dexamethasone
3
2007
431
0.080
 Why?
Sphingosine
1
2009
28
0.080
 Why?
Organoids
1
2009
36
0.080
 Why?
Lysophospholipids
1
2009
44
0.080
 Why?
Prospective Studies
5
2016
2378
0.080
 Why?
Drug Screening Assays, Antitumor
1
2009
129
0.080
 Why?
Caspases
1
2009
103
0.080
 Why?
p38 Mitogen-Activated Protein Kinases
1
2009
90
0.080
 Why?
Leukocytes, Mononuclear
1
2009
118
0.080
 Why?
Enzyme Activation
1
2009
268
0.080
 Why?
Glucuronidase
2
2007
47
0.070
 Why?
Lentivirus
1
2008
17
0.070
 Why?
Wnt3 Protein
1
2008
7
0.070
 Why?
Immunoglobulin Light Chains
1
2009
83
0.070
 Why?
Ellipticines
1
2008
2
0.070
 Why?
Wnt3A Protein
1
2008
10
0.070
 Why?
Bone Density Conservation Agents
1
2009
74
0.070
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
68
0.070
 Why?
B-Cell Activating Factor
1
2007
3
0.070
 Why?
Precancerous Conditions
1
2008
83
0.070
 Why?
Cytological Techniques
1
2007
14
0.070
 Why?
Diploidy
1
2007
26
0.070
 Why?
Genetic Vectors
1
2008
128
0.070
 Why?
Phosphorylation
1
2009
520
0.070
 Why?
RNA, Messenger
2
2008
1085
0.070
 Why?
RNA Interference
1
2008
179
0.070
 Why?
Karyotyping
1
2007
65
0.070
 Why?
Heparan Sulfate Proteoglycans
1
2007
11
0.070
 Why?
Hematopoietic Stem Cell Transplantation
1
2012
580
0.070
 Why?
Neoplasm Staging
2
2007
738
0.070
 Why?
Reactive Oxygen Species
1
2009
408
0.070
 Why?
Mice, Inbred C57BL
1
2012
1796
0.070
 Why?
Phenotype
2
2009
736
0.070
 Why?
Models, Animal
1
2007
225
0.070
 Why?
Immunosuppressive Agents
1
2008
227
0.070
 Why?
Carrier Proteins
2
2008
297
0.060
 Why?
Risk Assessment
3
2018
1268
0.060
 Why?
Gelatinases
1
2006
32
0.060
 Why?
Endopeptidases
1
2006
64
0.060
 Why?
Survival Analysis
2
2018
658
0.060
 Why?
Antigens, CD19
1
2005
28
0.060
 Why?
Antigens, CD34
1
2005
75
0.060
 Why?
Fetal Tissue Transplantation
1
2005
10
0.060
 Why?
Hematologic Neoplasms
1
2006
99
0.060
 Why?
Molecular Sequence Data
1
2006
760
0.060
 Why?
Endothelium, Vascular
1
2006
244
0.060
 Why?
Receptor Activator of Nuclear Factor-kappa B
1
2004
32
0.060
 Why?
Annexin A5
1
2004
14
0.060
 Why?
Culture Media, Conditioned
1
2004
46
0.060
 Why?
Phagocytosis
1
2004
49
0.060
 Why?
Clinical Trials as Topic
3
2016
488
0.050
 Why?
Neoplasm Metastasis
1
2004
230
0.050
 Why?
Membrane Proteins
1
2006
337
0.050
 Why?
Pregnancy
1
2011
2444
0.050
 Why?
Polymerase Chain Reaction
1
2005
447
0.050
 Why?
Adult
5
2018
13561
0.050
 Why?
Endothelial Growth Factors
1
2002
9
0.050
 Why?
Vascular Endothelial Growth Factors
1
2002
13
0.050
 Why?
RANK Ligand
1
2004
186
0.050
 Why?
Lymphokines
1
2002
19
0.050
 Why?
Biotransformation
1
2002
84
0.050
 Why?
Oxidative Stress
1
2007
770
0.050
 Why?
Blotting, Western
2
2015
575
0.050
 Why?
Vascular Endothelial Growth Factor A
1
2002
180
0.050
 Why?
Oncogenes
1
2021
54
0.050
 Why?
Combined Modality Therapy
2
2016
640
0.050
 Why?
Chromatin
1
2021
133
0.040
 Why?
Imidazoles
1
2002
125
0.040
 Why?
Polycomb Repressive Complex 2
1
2021
46
0.040
 Why?
Liver Transplantation
1
2002
156
0.040
 Why?
Treatment Outcome
4
2017
5265
0.040
 Why?
Histones
1
2021
294
0.040
 Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
 Why?
Genes, Immunoglobulin Heavy Chain
1
2019
12
0.040
 Why?
Aged, 80 and over
2
2017
3233
0.040
 Why?
Radiography
2
2012
482
0.040
 Why?
In Situ Hybridization, Fluorescence
1
2019
231
0.040
 Why?
DNA-Binding Proteins
1
2021
410
0.040
 Why?
Tomography, X-Ray Computed
2
2017
1163
0.030
 Why?
False Positive Reactions
1
2017
59
0.030
 Why?
Metaphase
1
2016
45
0.030
 Why?
Liver
1
2002
1126
0.030
 Why?
Indolizines
1
2015
5
0.030
 Why?
Imaging, Three-Dimensional
1
2017
151
0.030
 Why?
Cyclic N-Oxides
1
2015
12
0.030
 Why?
Transcriptome
1
2018
314
0.030
 Why?
Survival Rate
1
2018
906
0.030
 Why?
Drug Synergism
1
2015
149
0.030
 Why?
S Phase
1
2015
18
0.030
 Why?
Genes, BRCA1
1
2015
19
0.030
 Why?
Follow-Up Studies
2
2013
2231
0.030
 Why?
Predictive Value of Tests
2
2007
924
0.030
 Why?
Enzyme-Linked Immunosorbent Assay
1
2015
227
0.030
 Why?
Transcription, Genetic
1
2015
354
0.030
 Why?
DNA Damage
1
2015
299
0.030
 Why?
Transfection
2
2004
353
0.030
 Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.020
 Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.020
 Why?
Acute Disease
1
2013
374
0.020
 Why?
Interleukin-2
1
2012
70
0.020
 Why?
Mice, Inbred NOD
1
2012
89
0.020
 Why?
Immunoenzyme Techniques
1
2012
140
0.020
 Why?
Lymphocyte Activation
1
2012
169
0.020
 Why?
Radiation-Sensitizing Agents
1
2010
51
0.020
 Why?
Incidence
1
2013
1027
0.020
 Why?
Inhibitor of Apoptosis Proteins
1
2009
21
0.020
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2009
13
0.020
 Why?
Protein Transport
1
2010
183
0.020
 Why?
Microtubule-Associated Proteins
1
2009
66
0.020
 Why?
Peptides
1
2010
218
0.020
 Why?
Down-Regulation
1
2009
338
0.020
 Why?
CDC2-CDC28 Kinases
1
2008
11
0.020
 Why?
Salvage Therapy
1
2008
137
0.020
 Why?
Protein Binding
1
2009
648
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2009
224
0.020
 Why?
Proteins
1
2010
340
0.020
 Why?
Antineoplastic Agents, Hormonal
1
2007
49
0.020
 Why?
Cytogenetic Analysis
1
2007
74
0.020
 Why?
Chi-Square Distribution
1
2007
275
0.020
 Why?
Phospholipase C gamma
1
2006
4
0.020
 Why?
Cell Cycle
1
2008
227
0.020
 Why?
Caspase 9
1
2006
14
0.020
 Why?
Multivariate Analysis
1
2008
583
0.020
 Why?
Mitogen-Activated Protein Kinase 3
1
2006
49
0.020
 Why?
Cyclin D
1
2006
18
0.020
 Why?
Osteoprotegerin
1
2006
52
0.020
 Why?
Bone Marrow Transplantation
1
2007
135
0.020
 Why?
Cyclins
1
2006
38
0.020
 Why?
RNA, Neoplasm
1
2006
44
0.020
 Why?
src-Family Kinases
1
2006
50
0.020
 Why?
Case-Control Studies
1
2009
1152
0.020
 Why?
Mice, Inbred BALB C
1
2006
292
0.020
 Why?
Chromosome Mapping
1
2006
143
0.020
 Why?
Proto-Oncogene Proteins c-akt
1
2006
155
0.020
 Why?
Phosphatidylinositol 3-Kinases
1
2006
139
0.020
 Why?
Cluster Analysis
1
2006
209
0.020
 Why?
Kaplan-Meier Estimate
1
2007
462
0.020
 Why?
Data Interpretation, Statistical
1
2006
162
0.020
 Why?
Transplantation, Autologous
1
2007
480
0.010
 Why?
Logistic Models
1
2007
901
0.010
 Why?
DNA, Complementary
1
2004
134
0.010
 Why?
Dose-Response Relationship, Drug
1
2007
1369
0.010
 Why?
Young Adult
1
2013
4075
0.010
 Why?
Recombinant Proteins
1
2004
477
0.010
 Why?
Randomized Controlled Trials as Topic
1
2005
567
0.010
 Why?
Solubility
1
2002
71
0.010
 Why?
Leukemia, Plasma Cell
1
2002
32
0.010
 Why?
Protein Structure, Tertiary
1
2002
241
0.010
 Why?
Adolescent
1
2013
6453
0.010
 Why?
Neoplasm Invasiveness
1
2002
269
0.010
 Why?
Retrospective Studies
1
2005
6274
0.010
 Why?
Yaccoby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (332) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department